Stenocare AS
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
Stenocare AS (STENO) - Total Assets
Latest total assets as of December 2025: Dkr12.64 Million DKK
Based on the latest financial reports, Stenocare AS (STENO) holds total assets worth Dkr12.64 Million DKK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Stenocare AS - Total Assets Trend (2018–2025)
This chart illustrates how Stenocare AS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Stenocare AS - Asset Composition Analysis
Current Asset Composition (December 2025)
Stenocare AS's total assets of Dkr12.64 Million consist of 37.3% current assets and 62.7% non-current assets.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 6.2% |
| Accounts Receivable | Dkr3.00 Million | 23.7% |
| Inventory | Dkr307.00K | 2.4% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr0.00 | 0.0% |
| Goodwill | Dkr7.58 Million | 60.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Stenocare AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Stenocare AS's current assets represent 37.3% of total assets in 2025, a decrease from 99.9% in 2018.
- Cash Position: Cash and equivalents constituted 6.2% of total assets in 2025, down from 83.6% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is goodwill at 60.0% of total assets.
Stenocare AS Competitors by Total Assets
Key competitors of Stenocare AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Stenocare AS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Stenocare AS generates 0.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Stenocare AS is currently not profitable relative to its asset base.
Stenocare AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.52 | 0.70 | 6.49 |
| Quick Ratio | 1.42 | 0.66 | 6.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr1.62 Million | Dkr -2.23 Million | Dkr 20.31 Million |
Stenocare AS - Advanced Valuation Insights
This section examines the relationship between Stenocare AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 25.52 |
| Latest Market Cap to Assets Ratio | 0.32 |
| Asset Growth Rate (YoY) | -35.8% |
| Total Assets | Dkr12.64 Million |
| Market Capitalization | $4.04 Million USD |
Valuation Analysis
Below Book Valuation: The market values Stenocare AS's assets below their book value (0.32 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Stenocare AS's assets decreased by 35.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Stenocare AS (2018–2025)
The table below shows the annual total assets of Stenocare AS from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Dkr12.64 Million | -35.82% |
| 2024-12-31 | Dkr19.69 Million | -48.34% |
| 2023-12-31 | Dkr38.12 Million | -3.74% |
| 2022-12-31 | Dkr39.60 Million | -9.86% |
| 2021-12-31 | Dkr43.94 Million | -22.02% |
| 2020-12-31 | Dkr56.34 Million | +78.25% |
| 2019-12-31 | Dkr31.61 Million | +45.59% |
| 2018-12-31 | Dkr21.71 Million | -- |